WGO Graded Evidence: Hepatitis B

Level: Cascade and Global Epidemiology: 9 Abstracts

Legend:   no star : Special Mention | : Important | : Very Important | : Key Development
	A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis. Veazjalali M, Norder H, Magnius L, Jazayeri SM, Alavian SM, Mokhtari-Azad T, J Viral Hepat. 2009 Apr;16(4):259-64
	HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Yuen MF, Wong DK, Fung J, Ip P, But D, Hung I, Lau K, Yuen JC, Lai CL, Gastroenterology. 2008 Oct;135(4):1192-9
	Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination. Sun HY, Ko WC, Tsai JJ, Lee HC, Liu CE, Wong WW, Su SC, Ho MW, Cheng SH, Yang CH, Lin YH, Miao WJ, Sheng WH, Hung CC, Am J Gastroenterol. 2009 Apr;104(4):877-84
	Epidemiology of hepatocellular carcinoma in Japan. Umemura T, Ichijo T, Yoshizawa K, Tanaka E, Kiyosawa K, J Gastroenterol. 2009;44 Suppl 19:102-7
	How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore. Ong SC, Lim SG, Li SC, J Viral Hepat. 2009 Jan;16(1):53-63
	Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India. Sukriti, Pati NT, Sethi A, Agrawal K, Agrawal K, Kumar GT, Kumar M, Kaanan AT, Sarin SK, J Gastroenterol Hepatol. 2008 Nov;23(11):1710-5
	Study of the Association Between Polymorphisms of the COL1A1 Gene and HBV-Related Liver Cirrhosis in Chinese Patients. Zhao YP, Wang H, Fang M, Ji Q, Yang ZX, Gao CF Dig Dis Sci. 2008 Jun 7;
Supplementary evidence:
	Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Zhang HW, Yin JH, Li YT, Li CZ, Ren H, Gu CY, Wu HY, Liang XS, Zhang P, Zhao JF, Tan XJ, Lu W, Schaefer S, Cao GW, Gut. 2008 Dec;57(12):1713-20
	HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study. Fang ZL, Sabin CA, Dong BQ, Ge LY, Wei SC, Chen QY, Fang KX, Yang JY, Wang XY, Harrison TJ, Am J Gastroenterol. 2008 Sep;103(9):2254-62